Tuesday, May 12, 2026

SPAGYRIC HERBALISM

Bitter tasting herbal extracts stimulate gastric cells




The Leibniz Institute for Food Systems Biology at the Technical University of Munich has now gained new insights




Leibniz-Institut für Lebensmittel-Systembiologie an der TU München

Dr. Phil Richter in the lab 

image: 

Dr. Phil Richter in a lab of the Leibniz Institute for Food Systems Biology at the Technical University of Munich.

view more 

Credit: Dr. Gisela Olias / Leibniz-LSB@TUM





Bitter-tasting herbal extracts have traditionally been used to support digestion, yet the molecular basis of their effects has remained largely unclear. The Leibniz Institute for Food Systems Biology at the Technical University of Munich has now gained new insights into this mechanism. Using a cellular model, its researchers demonstrated that herbal extracts can stimulate proton secretion in human gastric cells as key mechanism of gastric acid production, with combinations of extracts showing particularly strong effects. Extracts rich in polyphenols proved especially potent. The study further identified three human bitter taste receptor subtypes as key mediators of this response.

The researchers investigated a commercially available herbal preparation commonly used to alleviate digestive complaints. The formulation consists of extracts from nine plants and is characterized by a pronounced bitter taste. Based on this, the scientists hypothesized that the bitter compounds it contains, including polyphenols, not only activate bitter taste receptors in the mouth, but also stimulate gastric acid secretion through extraoral bitter taste receptors located in the stomach. Roughly 25 different human bitter taste receptor subtypes are known.

Four herbal extracts found to be especially effective

To test this hypothesis, the research team led by first author Phil Richter and principal investigator Veronika Somoza analyzed both the effects of individual plant extracts and three different extract mixtures using a cell-based testing system. Their experiments revealed that several extracts, especially those from masterwort, juniper, sage, and yarrow, enhanced proton secretion in human gastric cells. In contrast, extracts from plants such as dandelion and gentian did not produce significant effects within the tested concentration range of up to 300 micrograms per milliliter.

The study also found that extracts with particularly high polyphenol levels exerted the strongest stimulatory effects. The researchers therefore propose that these phytochemicals may play an important role in promoting gastric acid secretion. Additional molecular biology analyses further indicated that the bitter taste receptors TAS2R4, TAS2R5, and TAS2R39 are involved in mediating the observed increase in proton secretion.

Variety is key

“Comparing the different extract mixtures yielded particularly interesting results,” explains Phil Richter. “The combination containing all nine plant extracts produced the strongest stimulation of cellular proton secretion. In contrast, the mixture composed of the four most active individual extracts showed a considerably weaker effect, while the blend of the five least active extracts triggered only a slight increase in proton secretion.”

According to the researcher, the findings indicate that cellular response emerges through the interaction of multiple compounds that enhance one another’s effects. “Our data suggest that several bitter taste receptor types are activated simultaneously,” says Phil Richter. “Apart from polyphenols, other plant constituents are also likely to contribute to this synergistic effect”, adds Veronika Somoza.

The study therefore offers a potential molecular explanation for why bitter-tasting herbal preparations have long been regarded as digestive aids. By activating bitter taste receptors in the stomach, these compounds may directly stimulate gastric acid secretion and thereby support digestive processes. The results also indicate that complex herbal mixtures can, in some cases, be more effective than isolated extracts.

At the same time, Veronika Somoza, head of the Metabolic Function & Biosignals research group at the Leibniz Institute, cautions that the findings are currently based on cell culture experiments. Future clinical studies will be necessary to determine whether comparable effects occur in humans. Nevertheless, the researcher believes that the new insights could help guide the development of more targeted herbal formulations in the future.

Publication: Richter, P., Piqué-Borràs, M.-R., Künstle, G., Somoza, V. (2026). A Digestive Herbal Mixture Preparation Stimulates Proton Secretion in Human Parietal Cells through Phenolic Compounds Targeting Bitter Taste Receptors. Mol. Nutr. Food Res. 70, 6. doi.org/10.1002/mnfr.70443

Funding: The authors declare that this study was financially supported by Weleda AG. The funder was not involved in the study design, data collection, analysis, or evaluation, the writing of this article, or the decision to submit it for publication.

Two of the co-authors declare the following financial conflicts of interest: M.-R. Piqué-Borràs and G. Künstle are employed by Weleda AG in Arlesheim, Switzerland.

More Information:

The study was based on extracts from nine plants: common wormwood, common sage, common yarrow, common centaury, common chicory, great yellow gentian, common juniper, masterwort, and common dandelion.

Phenolic compounds, also known as polyphenols, are among the most important phytochemicals. They are credited with a wide range of health-promoting effects, including immunomodulatory and anti-inflammatory properties. Recent research findings also show that polyphenols can specifically target so-called bitter taste receptors (TAS2Rs).

Bitter taste receptors are widespread throughout the human body. A total of about 25 different types are known. Originally, they were primarily associated with the perception of bitter tasting substances in the oral cavity. It is now known that these receptors are also found outside the mouth, for example on blood cells as well as on cells of organs such as the brain, the heart, and the gastrointestinal tract. It is not yet fully understood what functions they perform in these locations or which substances activate the so-called extraoral bitter taste receptors. These open questions are the focus of current research, including at the Leibniz Institute for Food Systems Biology at the Technical University of Munich.

Contacts:
Expert Contacts:

Prof. Dr. Veronika Somoza
Head of Section II and the Metabolic Function & Biosignals research group at the
Leibniz Institute for Food Systems Biology
at the Technical University of Munich (Leibniz-LSB@TUM)
Lise-Meitner-Str. 34
85354 Freising
Email: v.somoza.leibniz-lsb(at)tum.de

Dr. Phil Richter
Metabolic Function & Biosignals research group
Phone: +49 8161 71-2932
Email: p.richter.leibniz-lsb(at)tum.de

Press Contact at Leibniz-LSB@TUM:

Dr. Gisela Olias
Knowledge Transfer, Press and Public Relations
Phone: +49 8161 71-2980
Email: g.olias.leibniz-lsb(at)tum.de

www.leibniz-lsb.de

Information About the Institute:

The Leibniz Institute for Food Systems Biology at the Technical University of Munich (Leibniz-LSB@TUM) comprises a unique research profile at the interface of Food Chemistry & Biology, Chemosensors & Technology, and Bioinformatics & Machine Learning. As this profile has grown far beyond the previous core discipline of classical food chemistry, the Institute spearheads the development of a food systems biology. Its aim is to develop new approaches for the sustainable production of sufficient quantities of food whose biologically active effector molecule profiles are geared to health and nutritional needs, but also to the sensory preferences of consumers. To do so, the Institute explores the complex networks of sensorically relevant effector molecules along the entire food production chain with a focus on making their effects systemically understandable and predictable in the long term.

A Member of the Leibniz Associatation

The Leibniz-LSB@TUM is a member of the Leibniz Association, which connects 96 independent research institutions. Their orientation ranges from the natural sciences, engineering and environmental sciences through economics, spatial and social sciences to the humanities. Leibniz Institutes address issues of social, economic and ecological relevance.They conduct basic and applied research, including in the interdisciplinary Leibniz Research Alliances, maintain scientific infrastructure, and provide research-based services. The Leibniz Association identifies focus areas for knowledge transfer, particularly with the Leibniz research museums. It advises and informs policymakers, science, industry and the general public.

Leibniz institutions collaborate intensively with universities – including in the form of Leibniz ScienceCampi – as well as with industry and other partners at home and abroad. They are subject to a transparent, independent evaluation procedure. Because of their importance for the country as a whole, the Leibniz Association Institutes are funded jointly by Germany’s central and regional governments. The Leibniz Institutes employ around 21,400 people, including 12,200 researchers. The financial volume amounts to 2,3 billion euros.

Note on the use of AI

The press release was first translated from German into American English using DeepL Pro. Prof. Veronika Somoza then reviewed the text for factual and linguistic accuracy, making corrections where necessary.

+++ Stay up to date via our LinkedIn channel +++

 

NYU's Quantum Institute, IBM team up for postdoctoral research program in quantum computing



Joint postdoctoral research projects will focus on quantum algorithms and applications in research areas across chemistry, computer science, materials science, physics, optimization, and more




New York University






New York University and IBM have initiated a postdoctoral program to conduct quantum computer research in the areas of chemistry, computer science, engineering, materials science, physics, and optimization.

This collaboration, as part of NYU’s role as a member of the IBM Quantum Network—a consortium of academic institutions, enterprises, startups, and government labs working to enhance quantum computing through research excellence and technological advancement—is intended to push quantum algorithms and applications development for today’s quantum-centric supercomputer architectures, which combine quantum and classical HPC workloads, as well as for future, large-scale, fault-tolerant quantum computers, which are expected to accelerate time and cost efficiencies in fields such as drug development, materials discovery, chemistry, and optimization.

“Quantum computing’s potential to understand and address engineering, mathematical, and scientific barriers is unmatched,” says NYU Professor Javad Shabani, director of NYU’s Quantum Institute, who will oversee the university’s role in the postdoc program. “But maximizing its contributions requires developing a network of quantum pioneers across academia and industry who can reach beyond today’s technological boundaries. NYU welcomes the opportunity to work with IBM to help postdocs with their innovative and comprehensive approaches in meeting these challenges.”

“This postdoctoral research sponsorship will give some of NYU’s top talent an opportunity to push IBM’s quantum-centric supercomputing architecture not just for immediate application development, but to lay the groundwork for the algorithms that will power tomorrow’s fault-tolerant quantum computers—all while engaging with the broader quantum community of students, researchers, and industry professionals,” says Jamie Garcia, Director, Growth & Strategic Partnerships, IBM. 

NYU postdoctoral researchers chosen for the program will conduct quantum-related projects, sponsored and supported by IBM and the company’s quantum researchers, at NYU’s Quantum Institute and at IBM Research headquarters—the Thomas J. Watson Research Center in Yorktown Heights, New York—using the company’s quantum computers. The program follows an earlier NYU-IBM program, which included the training of NYU undergraduates and graduates in quantum information physics.

NYU’s Quantum Institute

Last fall, the university established the NYU Quantum Institute, which aims to drive cutting-edge research across three pillars of quantum information science—quantum computing, quantum communications, and quantum sensing—while also serving as a hub for the exchange of ideas and interactions between academia and the private sector, including New York’s startup ecosystem. 

“When we launched the Quantum Institute at NYU, its success was to be based on the ingenuity of the outstanding faculty and students leading innovation at NYU, but of equal importance was the collaboration with industry leaders—such as IBM,” notes Juan De Pablo, Anne and Joel Ehrenkranz Executive Vice President for Global Science and Technology and executive dean of the Tandon School of Engineering. “Together we can help make New York a vital part of the quantum universe.”

# # #

 

Vertigo can carry lasting burden even after successful treatment, seven-year study finds





New research reinforces the AAO-HNSF BPPV clinical practice guideline update and connects to the foundation’s new national initiative on age-friendly care




American Academy of Otolaryngology - Head and Neck Surgery





A new long-term study published in Otolaryngology–Head and Neck Surgery, the official peer-reviewed publication of the American Academy of Otolaryngology–Head and Neck Surgery Foundation (AAO-HNSF), reveals that benign paroxysmal positional vertigo (BPPV), the most common cause of vertigo, continues to affect patients significantly even years after successful initial treatment. Among 361 patients who followed for seven years, nearly half (47.1%) experienced at least one recurrence, more than a third (37.6%) reported persistent residual dizziness, and nearly one in five (18.9%) suffered a fall.

BPPV is caused by displaced calcium crystals (otoconia) in the inner ear and is typically treated with repositioning maneuvers. While these maneuvers are highly effective in the short term, this study—conducted at Getafe University Hospital in Madrid, Spain—demonstrates that the condition carries meaningful long-term consequences for both clinicians and patients.

These findings align with key recommendations in the AAO-HNSF Clinical Practice Guideline (CPG) update on BPPV. The CPG emphasizes canal-specific repositioning maneuvers as first-line therapy—the same approach used in this study—and addresses patient education, vestibular rehabilitation, and follow-up for those who do not fully resolve after initial treatment.

Additionally, the long-term fall risk documented in this study underscores the importance of the AAO-HNSF's recently awarded grant by the Council of Medical Specialty Societies, with support from The John A. Hartford Foundation, to advance age-friendly care in otolaryngology. This national initiative, which includes fall risk as a key focus area, aims to improve care for older adults by integrating age-friendly principles into otolaryngology practice across the United States.

“Otolaryngologists are on the front lines of addressing some of the most significant health challenges facing older adults, from hearing loss and its connection to cognitive decline to vestibular dysfunction and fall risk,” said Rahul K. Shah, MD, MBA, AAO-HNSF Executive Vice President and CEO. “The CMSS grant allows us to equip our members with specialty-specific, evidence-based tools that continue to put patients at the center of their care—empowering older adults to have more meaningful conversations with their doctors about what matters most to them.”

With BPPV prevalence nearly seven times higher in adults over 60, vestibular disorders represent a critical priority in age-friendly care. The AAO-HNSF initiative will provide clinicians with specialty-specific tools, training, and frameworks to translate evidence like this into practice-level change.

Study Citation: Martin-Sanz, E., Chaure-Cordero, M., Fernández-Navarro, C., Solis-Fesser, A. and Riestra-Ayora, J. (2026), Long-Term Benign Paroxysmal Positional Vertigo: Recurrence, Residual Symptoms and Risk of Falls. Otolaryngol Head Neck Surghttps://doi.org/10.1002/ohn.70257

Otolaryngology–Head and Neck Surgery
Otolaryngology–Head and Neck Surgery (OTO Journal) is the official peer-reviewed publication of the American Academy of Otolaryngology–Head and Neck Surgery Foundation. Our mission is to publish contemporary, ethical, clinically relevant information in otolaryngology, head and neck surgery (ear, nose, throat, head, and neck disorders) that can be used by otolaryngologists, clinicians, scientists, and specialists to improve patient care and public health.

About the AAO-HNS/F
The AAO-HNS/F is one of the world’s largest organizations representing specialists who treat the ears, nose, throat, and related structures of the head and neck. Otolaryngologist-head and neck surgeons diagnose and treat medical disorders that are among the most common affecting patients of all ages in the United States and around the world. Those medical conditions include chronic ear disease, hearing and balance disorders, hearing loss, sinusitis, snoring and sleep apnea, allergies, swallowing disorders, nosebleeds, hoarseness, dizziness, and tumors of the head and neck as well as aesthetic and reconstructive surgery and intricate micro-surgical procedures of the head and neck. The Academy has approximately 13,000 members. The AAO-HNS Foundation works to advance the art, science, and ethical practice of otolaryngology-head and neck surgery through education, research, and quality measurement.

 

 

A new way to capture water — from air and with sunlight



Chemists design a light-triggered structure that could alleviate global water scarcity



University of Iowa

Mini water storage units 

image: 

Chemists led by the University of Iowa have created a three-dimensional structure that captures water from the air and stores it. The box-like illustration in the center shows the structure before (left side) and after undergoing a chemical reaction involving sunlight (flames in center). The resulting lattice (right side) includes cavities that capture and store water molecules. The diagrams in the upper left and lower right show the chemical arrangement before and after the light-induced reaction.

view more 

Credit: Nevindee Samararathne and Leonard MacGillivray group at University of Iowa/Universite de Sherbrooke, Canada, Tamador Alkhidir and Sharmarke Mohamed group at Khalifa University of Science and Technology, Abu Dhabi, United Arab Emirates)





Chemists at the University of Iowa have created a three-dimensional lattice that captures water from the air and stores it.

In a new study, researchers describe a millimeter-scale structure made of metal atoms connected by two types of organic molecules. When exposed to ultraviolet light, the material undergoes a chemical reaction that changes its shape, creating cavities throughout the lattice. Those cavities attract water molecules from the air and store them — like a multitude of tiny canteens.

The results, which would need to be tested at larger scales, show promise as a method to help provide drinking water to people and areas with limited access. Water stress or scarcity will affect nearly 5 billion people — half the world’s projected population — by 2050, according to the United Nations.

“We have found and validated a way to capture and to store water that would require only sunlight,” says Leonard MacGillivray, adjunct professor in the Department of Chemistry and former professor and department chair. “You can transport the crystal lattice and eventually release the water on demand. That’s why it’s such an advance.”

MacGillivray’s group discovered the water-capturing architecture while tinkering with metal-organic frameworks (MOFs), which combine metal atoms and organic linkers to form 3D structures with pore-like openings. The technique, developed in the 1990s, earned its pioneers the 2025 Nobel Prize in chemistry.

The Iowa team’s initial attempts at creating MOFs yielded no cavities.

“Our design had linkers, which should give us pores, but flexibility we had built into the linkers did not allow for cavities to form,” says Nevindee Samararathne Muhandiramge, a graduate student in MacGillivray’s lab and the study’s first author.

But when the researchers exposed the structure to ultraviolet light, cavities formed inside the crystals — with an additional surprise.

“Lo and behold, when we looked at the internal structure of the crystal using X-ray diffraction, we found water inside,” MacGillivray says.

The UV light-induced chemical reaction is the key element to the water-capturing lattice. Linkers within the framework, which loosely resemble pairs of parallel lines in the letter “H,” rearrange into an X-shaped pattern when exposed to light. In three dimensions, this creates numerous cavities, each capable of capturing and storing two water molecules, which equates to 5% of the filled structure’s mass.

“We do not know exactly how the water molecules travel into the crystal, but they're probably hydrogen bonding on the surface to some extent,” MacGillivray says. “When the light hits the crystal, all these cavities start to pop open, water migrates in, then finds a resting place in the cavities.”

Although each cavity stores a small amount of water, scale could make the approach impactful, the chemists note. These chain-like configurations can, in principle, be produced nearly endlessly.

“They assemble themselves for us,” says MacGillivray, who is Canada Excellence Research Chair at the University of Sherbrooke in Quebec. “There are countless numbers, so this is a good start.”

The researchers write in the paper the method could “advance developments in intelligent water harvesting technologies.”

“The reason why we use the word ‘intelligent’ is because we're triggering the water capture intentionally with the light,” Samararathne Muhandiramge explains. “UV light is freely available from the sun. So, the next step would be to determine the limits of the water uptake in terms of mass percent and push that limit as far as we can.”

The researchers used cadmium atoms as a proof of concept and are investigating less toxic alternatives.

The study, “Photo capture of water by single crystals of a nonporous metal−organic material,” was published online March 30 in the Journal of the American Chemical Society.

Study authors include Davide Proserpio of the Università degli Studi di Milano, in Italy; Eric Reinheimer of Rigaku Americas Corporation in The Woodlands, Texas; Farshid Effaty of the University of Sherbrooke; and Tamador Alkhidir and Sharmarke Mohamed of Khalifa University of Science and Technology in Abu Dhabi, United Arab Emirates.

The U.S. National Science Foundation funded the research.

Analyses using X-ray diffraction and thermal techniques were performed at the Materials Analysis, Testing, and Fabrication Facility, created at Iowa in 2019 by the Office of the Vice President for Research to advance micro-nanofabrication research.

 

Why similar genes can lead to very different brains, a new study offers clues




Hiroshima University
RBP diversity–brain complexity relationship study 

image: 

Across six model organisms, RNA-binding protein (RBP) family diversity increased alongside neuron count—from nematode worms to humans—suggesting a potential link to nervous system complexity.

view more 

Credit: Kyota Yasuda/Hiroshima University





As more and more genomes of model organisms were sequenced, scientists quickly understood that the number of genes an organism possesses doesn’t always correlate with the complexity of an organism. This fact is referred to as the G-value paradox.

Generally speaking, higher-order organisms like humans have more complex genomes than simpler organisms, but they don’t necessarily have more protein-coding genes. In fact, humans have roughly the same number of protein-coding genes (roughly 20,000–25,000) as a nematode worm.

Evolutionary biologists have been searching for other factors that can explain the increased complexity of some organisms over others beyond an organism’s quantity of protein-coding genes, or G-value. One of the ways organisms enhance their complexity without increasing the number of protein-coding genes in the genome is through post-transcriptional regulation.

Post-transcriptional regulation refers to molecular processes that can alter RNAs before they are translated into the proteins an organism uses for metabolism, structure, transport of ions, nutrients, and waste, and communication between cells. Many of these processes are controlled by RNA-binding proteins (RBPs), which help determine how messenger RNAs are spliced, processed, and translated into proteins.

First to examine the RBP diversity–brain complexity relationship

No studies had ever been conducted, however, to establish whether a higher diversity of RBPs present in an organism correlates with increased organism complexity. Kyota Yasuda, an assistant professor in the Graduate School of Integrated Sciences for Life at Hiroshima University, Japan, decided to address this issue by comparing RBP diversity and other factors to nervous system complexity in several species. Yasuda is also a member of Hiroshima University’s International Institute for Sustainability with Knotted Chiral Meta Matter (WPI-SKCM2).

The study was published on May 4 in the journal iScience.

“This study asks a fundamental question in biology: why do some animals, especially vertebrates and humans, have much more complex nervous systems than others? This is important because it highlights post-transcriptional regulation as a potential molecular foundation of nervous system complexity, and it may also help explain why vertebrate nervous systems are especially vulnerable to disorders linked to RBPs,” said Yasuda.

Yasuda analyzed the RBPs in six different metazoan (multicellular, eukaryotic animal) model organisms to identify specific domains incorporated in each RBP protein and protein family. He found that the number of different RBP families, each incorporating a different complement of protein domains, increased from invertebrate to vertebrate animals: 397 families in C. elegans nematode worms, 419 in D. melanogaster fruit flies, 455 in D. rerio zebrafish, 446 in X. tropicalis western clawed frog, 472 in M. musculus mouse, and 469 in humans. There was also a strong correlation between enhanced RBP diversity and neuronal count (Spearman's rank order correlation coefficient ρ = 0.886, p = 0.019, n = 6) as well as genome size and cell-type diversity. The correlation spans more than six orders of magnitude in neuron number — from 302 neurons in C. elegans to about 86 billion in humans.

The pattern holds across species

The initial results were also supported by an analysis of 13 total metazoan species, adding turtle, chicken, sea squirt, lancelet, honeybee, octopus, and mosquito. The data showed lower resolution than the six-species analysis, but still indicated a positive correlation between increased RBP diversity and neuronal count.

Yasuda also analyzed the length and complexity of 3’ untranslated regions (UTRs) in genes from nematode worms, fruit flies, zebrafish, frogs, mice, and humans—regions where RBPs regulate splicing and gene expression. He found that the median 3’UTR length increased about 8.9-fold from worm (163 nucleotides or nt) to human (1,444 nt) and correlated strongly with neural complexity (ρ = 0.943, p = 0.0048). This effect was not observed with the length of 5’UTR regions or gene coding sequence (CDS), however.

Further, the domains that expanded most strongly in vertebrates were not limited to classical neural RNA regulators, but included proteins linked to RNA modification, RNA catabolism or breakdown, innate immunity, and genome maintenance. This suggests that brain complexity may rest on a broader post-transcriptional regulatory foundation than previously appreciated.

More RBP diversity linked to more complex brains

Yasuda also compared the enhanced complexity observed in RBPs with that of other protein classes across the same six model organisms to determine whether increased complexity in other proteins could also account for the more complex nervous systems observed in higher organisms. For example, transcription factors help assemble the protein apparatus necessary to transcribe genes that will be made into proteins. Transcription factor diversity increases in the six original model species, but reaches a saturation point where the number of transcription factor Pfam families maxes out at 72 across all four vertebrate species (zebrafish, frog, mouse, human, all = 72). By contrast, RBP family diversity continues to vary among vertebrates, indicating a more continuous positive relationship with nervous system complexity.

“The central message is that RNA-binding protein family diversity closely tracks neural complexity across animals. Unlike transcription factors, which appear to reach a ceiling in vertebrates, RNA-binding protein families continue to diversify. This suggests that the expansion of post-transcriptional regulatory capacity is a distinctive molecular feature of complex nervous systems,” said Yasuda. “If the genome is a library, transcription factors help decide which books are opened. RNA-binding proteins, in turn, help determine how the text is processed, interpreted, and delivered. As this regulatory layer becomes richer, nervous systems appear able to support greater complexity.”

This initial study provides a framework for future studies that assess the effect of RBPs on the nervous system.

“The next step is to test experimentally whether the vertebrate-expanded RNA-binding protein families identified in this study play functional roles in nervous system development and complexity. My ultimate goal is to understand how the diversification of post-transcriptional regulation contributed to the evolutionary emergence of complex nervous systems, and how the same molecular innovations may also create vulnerability to neurodegenerative disease,” said Yasuda.

This work was financially supported by JSPS KAKENHI Grant-in-Aid for Scientific Research (C) (Grant Number: 23K05147).

###

About Hiroshima University

Since its foundation in 1949, Hiroshima University has striven to become one of the most prominent and comprehensive universities in Japan for the promotion and development of scholarship and education. Consisting of 12 schools for undergraduate level and 5 graduate schools, ranging from natural sciences to humanities and social sciences, the university has grown into one of the most distinguished comprehensive research universities in Japan. English website: https://www.hiroshima-u.ac.jp/en

 

$12 million grant will advance Henry Ford Health's suicide prevention model across the US



A multimillion-dollar gift from the Four Pines Fund will help enhance and expand suicide prevention programming.




Henry Ford Health






DETROIT — May 11, 2026 — A $12 million philanthropic grant from the Four Pines Fund will help expand Henry Ford Health’s proven framework for reducing patient suicide attempts within health systems.

Suicide prevention experts will use the grant to expand and enhance access to effective suicide care across Henry Ford Health, Kaiser Permanente Colorado and HealthPartners in Minnesota, as well as establish a new suicide prevention center at Henry Ford Health.

Suicide remains a persistent public health challenge in the United States. According to the latest statistics from the Centers for Disease Control and Prevention, more than 49,000 people died by suicide in the U.S. in 2023 and 12.8 million seriously considered suicide.

Henry Ford Health pioneered a suicide prevention program known as the  Zero Suicide Model more than 25 years ago and has since used it to identify patients in crisis and intervene early, leading to a dramatic reduction in suicides across its patient population. A 2025 study published in JAMA Network Open showed that by adopting the ZS Model, health systems can reduce suicide rates among patients by 25% or more.  Data shows more than 80% of people who die by suicide and more than 90% of people who attempt suicide visit a doctor’s office in the months and weeks leading up to their death.

“Our goal with Zero Suicide has always been to save more lives,” said Brian K. Ahmedani, Ph.D., director of research for Behavioral Health Services at Henry Ford Health. “The generous gift from the Four Pines Fund allows us to grow suicide care within our own health system and share our expertise with colleagues across the country so that more patients receive the right treatment, at the right time.”

The Henry Ford Health approach starts with a suicide risk screening that patients fill out before they see their regular doctor. Providers immediately evaluate the survey; if a patient screens positive, they are further assessed for suicide risk. Those at elevated risk work with a specialized member of the care team to create a safety plan that covers who they can call if they’re in distress, cognitive tools for reducing suicidal thoughts and what they can do to make their home environment safe. The patient is also referred to an outpatient behavioral health provider for psychotherapy focused on suicide prevention.

The $12 million gift from the Four Pines Fund will support efforts to substantially expand services for patients at risk, including introducing more advanced and accessible safety planning support and virtual therapy for patients at mild-to-moderate suicide risk.

The gift will also help fund the establishment of an integrated suicide prevention center within Henry Ford Health that is designed for comprehensive suicide care, clinical innovation and provider training.

“This integrated center will be a place where our priorities for suicide prevention and care will sit front and center,” said Dr. Deepak Prabhakar, chair of Psychiatry and Behavioral Medicine at Henry Ford Health. “As pioneers in suicide prevention, it’s our responsibility to continue piloting novel solutions and developing education and training materials that help save the lives of people in our community and can be replicated across the country and around the globe.”

Four Pines Fund is dedicated to expanding access to evidence based suicide care across the U.S. Henry Ford Health’s award is one of five grants made by the fund in 2026 to accelerate national adoption of effective suicide prevention practices within health care systems.

“We’re deeply humbled by the support of Four Pines Fund. This gift will support rapid innovation and inspire national change as we strive to prevent suicides and support our patients in living healthier lives,” said Mary Jane Vogt, executive vice president and chief development officer at Henry Ford Health.

Click here to learn more about Henry Ford Zero Suicide.

###

Media Contact: mediarelations@hfhs.org

 

Positive emotion and reward disturbance in mood disorders



A free webinar from the Brain & Behavior Research Foundation



Brain & Behavior Research Foundation





We know that positive emotions motivate us to pursue important goals, savor experiences, counteract the cardiovascular effects of stress, and maintain vital social bonds. However, a relatively untouched question remains: Can positive emotions also be a source of dysfunction in particular contexts, or when not appropriately managed? In a free webinar, “Positive Emotion and Reward Disturbance in Mood Disorders” on Tuesday, May 12, 2026 at 2pm ET, Dr. Gruber will discuss her lab's work to delineate the nature of positive emotion disturbance in people with and without a history of mood difficulties. By studying healthy people, people at risk for mood disorders, as well as adults and adolescents with mood disorders, she seeks to develop new ways of understanding positive mood disturbance as well as treatments to enhance emotional well-being and sustainable happiness.

The guest speaker, June Gruber, Ph.D., is a professor in the Department of Psychology and Neuroscience at the University of Colorado Boulder. Dr. Gruber also received Young Investigator Grants in 2013 and 2019. The host, Jeffrey Borenstein, M.D., is President & CEO of the Brain & Behavior Research Foundation and host of the Emmy® nominated television series Healthy Minds.

Register Now

About Brain & Behavior Research Foundation

The Brain & Behavior Research Foundation awards research grants to develop improved treatments, cures, and methods of prevention for mental illness. These illnesses include addiction, ADHD, anxiety, autism, bipolar disorder, borderline personality disorder, depression, eating disorders, OCD, PTSD, and schizophrenia, as well as research on suicide prevention. Since 1987, the Foundation has awarded more than $476 million to fund more than 5,700 leading scientists around the world. 100% of every dollar donated for research is invested in research. BBRF operating expenses are covered by separate foundation grants. BBRF is the producer of the Emmy®-nominated public television series Healthy Minds with Dr. Jeffrey Borenstein, which aims to remove the stigma of mental illness and demonstrate that with help, there is hope.